Parkside Financial Bank & Trust Roivant Sciences Ltd. Transaction History

Parkside Financial Bank & Trust

  • $742 Million
  • Q4 2024

A detailed history of Parkside Financial Bank & Trust transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 206 shares of ROIV stock, worth $2,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares
206
Previous 195 5.64%
Holding current value
$2,175
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025
BUY
$11.16 - $12.71 $122 - $139
11 Added 5.64%
206 $2,000
Q1 2023

May 04, 2023
BUY
$6.92 - $9.98 $1,349 - $1,946
195 New
195 $1,000

Others Institutions Holding ROIV

# of Institutions
338
Shares Held
511M
Call Options Held
813K
Put Options Held
1.01M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $7.44B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email